A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three …
…, E Valeinis, D Den, R Mueller, G Tridello… - Journal of clinical …, 2013 - iris.unito.it
This phase III trial compared adjuvant whole-brain radiotherapy (WBRT) with observation
after either surgery or radiosurgery of a limited number of brain metastases in patients with …
after either surgery or radiosurgery of a limited number of brain metastases in patients with …
Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious …
D Averbuch, G Tridello, J Hoek… - Clinical Infectious …, 2017 - academic.oup.com
Background This intercontinental study aimed to study gram-negative rod (GNR) resistance
in hematopoietic stem cell transplantation (HSCT). Methods GNR bacteremias occurring …
in hematopoietic stem cell transplantation (HSCT). Methods GNR bacteremias occurring …
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the …
…, MC Menconi, P Bosman, M Mauro, G Tridello… - Bone marrow …, 2020 - nature.com
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative procedure in patients
with Shwachman–Diamond syndrome (SDS) with bone marrow abnormalities. The results …
with Shwachman–Diamond syndrome (SDS) with bone marrow abnormalities. The results …
[HTML][HTML] Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors
J Styczyński, G Tridello, L Koster, S Iacobelli… - Bone marrow …, 2020 - nature.com
Abstract Information on incidence, and factors associated with mortality is a prerequisite to
improve outcome after hematopoietic stem cell transplantation (HSCT). Therefore, 55′668 …
improve outcome after hematopoietic stem cell transplantation (HSCT). Therefore, 55′668 …
Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus–related lymphoproliferative disorder after hematopoietic stem cell transplant in …
J Styczynski, L Gil, G Tridello… - Clinical infectious …, 2013 - academic.oup.com
Background. The objective of this analysis was to investigate prognostic factors that
influence the outcome of Epstein-Barr virus (EBV)–related posttransplant lymphoproliferative …
influence the outcome of Epstein-Barr virus (EBV)–related posttransplant lymphoproliferative …
[HTML][HTML] COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
P Ljungman, R de la Camara, M Mikulska, G Tridello… - Leukemia, 2021 - nature.com
This study reports on 382 COVID-19 patients having undergone allogeneic (n = 236) or
autologous (n = 146) hematopoietic cell transplantation (HCT) reported to the European Society …
autologous (n = 146) hematopoietic cell transplantation (HCT) reported to the European Society …
A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
…, E Talenti, T Toffolutti, E Calore, G Tridello… - …, 2005 - haematologica.org
BACKGROUND AND OBJECTIVES: Veno-occlusive disease (VOD) is one of the most frequent
complications after stem cell transplantation. We conducted a prospective survey of 244 …
complications after stem cell transplantation. We conducted a prospective survey of 244 …
Knowledge and attitudes about cancer pain management: a national survey of Italian oncology nurses
M Bernardi, G Catania, A Lambert, G Tridello… - European Journal of …, 2007 - Elsevier
The purpose of this study was to obtain information about the knowledge and attitudes of
Italian oncology nurses concerning cancer pain management and to determine the predictors …
Italian oncology nurses concerning cancer pain management and to determine the predictors …
Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy
M Zignol, M Peracchi, G Tridello… - … Journal of the …, 2004 - Wiley Online Library
BACKGROUND To evaluate the effect of chemotherapy on humoral immunity to vaccine‐preventable
disease, the authors investigated the persistence of protective antibody titers in a …
disease, the authors investigated the persistence of protective antibody titers in a …
[HTML][HTML] Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for …
…, P Ljungman, R de La Camara, G Tridello… - Leukemia, 2021 - nature.com
COVID-19 is posing a significant threat to health in vulnerable patients, such as
immunocompromised patients. For hematopoietic cell transplantation (HCT) recipients and patients …
immunocompromised patients. For hematopoietic cell transplantation (HCT) recipients and patients …